{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-25-001687","form_type":"8-K","ticker":"GALT","cik":"0001133416","company_name":"GALECTIN THERAPEUTICS INC","filed_at":"2025-01-23T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.009352+00:00","generated_at":"2026-05-27T13:19:13.983765+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"low","headline":"Galectin Therapeutics furnishes annual meeting presentation transcript; no material new details disclosed","bullets":["Filed a transcript of a presentation made after the January 23, 2025 Annual Meeting of Stockholders under Item 7.01.","The provided transcript excerpt contains only an opening thank-you and a forward-looking statement disclaimer; substantive content is absent from the filing.","No financial results, pipeline updates, or guidance changes are reported in the furnished exhibit."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-25-001687","json":"https://secwatch.observer/filing/0001140361-25-001687.json","markdown":"https://secwatch.observer/filing/0001140361-25-001687.md","text":"https://secwatch.observer/filing/0001140361-25-001687.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1133416/000114036125001687/0001140361-25-001687-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1133416/000114036125001687/ef20042040_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-27T13:19:13.983765+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}